What is the recommended course of action for a patient with a Low-grade Squamous Intraepithelial Lesion (LSIL) pap result?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Low-grade Squamous Intraepithelial Lesion (LSIL) Pap Result

For patients with LSIL Pap results, referral to colposcopy is the recommended course of action for women aged ≥21 years, while repeat Pap testing at 12 and 24 months is recommended for women aged <21 years due to high rates of spontaneous clearance in younger populations. 1, 2

Age-Based Management Algorithm

For Women <21 Years:

  • Do not refer for colposcopy - high rates of spontaneous clearance make this unnecessary 1
  • Perform repeat Pap testing at:
    • 12 months
    • 24 months
  • Only refer to colposcopy if HSIL or greater is found on follow-up 2

For Women ≥21 Years:

  • Refer for colposcopy with a clinician who can perform examination of the lower genital tract and conduct colposcopically directed biopsy if indicated 1

Follow-Up After Colposcopy

If colposcopy is normal or shows CIN1:

  • Repeat Pap testing at 12 months 2
  • At 12-month follow-up:
    • If HPV test is negative → return to routine screening
    • If HPV test is positive → refer for colposcopy
    • If repeat cytology is negative → repeat again at 24 months
    • If repeat cytology shows ASC-US or greater → refer for colposcopy 2

Important Clinical Considerations

  • Documentation is crucial - all test results, follow-up appointments, and management decisions should be clearly documented in the patient's record 1, 2

  • Risk of progression - While most LSILs regress spontaneously (studies show regression rates of 81.1%), approximately 17% may progress to HSIL/CIN 2/3 3, 4

  • Risk of loss to follow-up - Delaying colposcopy in favor of repeat cytology can result in significant loss to follow-up (up to 42% in high-risk populations), which is a major concern 3

  • Marked cytological atypia - LSILs with marked atypia may have a higher risk of progression to HSIL (36% vs 7% for standard LSIL) and should be managed more aggressively 5

  • Avoid overtreatment - Diagnostic excisional procedures (like LEEP) are not recommended for women with initial LSIL in the absence of histologically diagnosed CIN 2/3 2

Referral Considerations

If colposcopy services are not available in the initial clinical setting:

  • Establish clear referral protocols to facilities that can provide prompt evaluation and treatment
  • Develop systems to track patients who miss follow-up appointments
  • Consider establishing colposcopy services in local health departments if referrals are difficult and follow-up is unlikely 1

By following these guidelines, clinicians can appropriately manage LSIL Pap results while minimizing both the risk of progression to higher-grade lesions and unnecessary interventions for lesions likely to regress spontaneously.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cervical Cancer Screening and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Conservative treatment of low grade squamous intraepithelial lesions (LSIL) of the cervix.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1998

Research

Low-grade squamous intraepithelial lesions of the cervix with marked cytological atypia-clinical follow-up and human papillomavirus genotyping.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.